Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months without the patient needing to take immunosuppressants.

Today, Benzinga's options scanner spotted 14 options trades for CRISPR Therapeutics. This is not a typical pattern. The sentiment among these major traders is split, with 28% bullish and 42% bearish.

A man with type 1 diabetes produces his own insulin after receiving genetically-modified donor islet cells, without the need ...

A man with type 1 diabetes has become the first patient to produce his own insulin after receiving genetically engineered cell transplants, without needing drugs to prevent rejection. The case, ...

Svetlana Mojsov has been named the winner of the 2026 Kimberly Prize in Biochemistry & Molecular Genetics from Northwestern University Feinberg School of Medicine and the Simpson Querrey Institute for ...

Turning genes on and off is like flipping a light switch, controlling whether genes in a cell are active. When a gene is ...